France’s Sanofi boosts rare disease business with about $2.2 billion Inhibrx deal January 24, 2024January 24, 2024
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference January 8, 2024January 8, 2024
Analysis-Unloved healthcare stocks draw investors despite US election risks January 8, 2024January 8, 2024
Wall St ekes out modest gains as S&P 500 hovers near all-time closing high December 27, 2023December 27, 2023
